Render Target: STATIC
Render Timestamp: 2024-07-26T09:47:25.716Z
View Featured Offers >>
1% for the planet logo
PDP - Template Name: Monoclonal Antibody
PDP - Template ID: *******c5e4b77
  1. Products /
  2. Primary Antibodies /
  3. Annexin A2 (D11G2) Rabbit mAb (BSA and Azide Free)
R Recombinant
Recombinant: Superior lot-to-lot consistency, continuous supply, and animal-free manufacturing.

Annexin A2 (D11G2) Rabbit mAb (BSA and Azide Free) #71123

Filter:
  • WB
  • IHC
  • IF
  • F

    Supporting Data

    REACTIVITY H M R Mk B Pg
    SENSITIVITY Endogenous
    MW (kDa) 38
    Source/Isotype Rabbit IgG
    Application Key:
    • WB-Western Blotting 
    • IHC-Immunohistochemistry 
    • IF-Immunofluorescence 
    • F-Flow Cytometry 
    Species Cross-Reactivity Key:
    • H-Human 
    • M-Mouse 
    • R-Rat 
    • Mk-Monkey 
    • B-Bovine 
    • Pg-Pig 

    Product Information

    Product Usage Information

    This product is the carrier free version of product #8235. All data were generated using the same antibody clone in the standard formulation which contains BSA and glycerol.

    This formulation is ideal for use with technologies requiring specialized or custom antibody labeling, including fluorophores, metals, lanthanides, and oligonucleotides. It is not recommended for ChIP, ChIP-seq, CUT&RUN or CUT&Tag assays. If you require a carrier free formulation for chromatin profiling, please contact us. Optimal dilutions/concentrations should be determined by the end user.

    Formulation

    Supplied in 1X PBS, BSA and Azide Free.

    For standard formulation of this product see product #8235

    Storage

    Store at -20°C. This product will freeze at -20°C so it is recommended to aliquot into single-use vials to avoid multiple freeze/thaw cycles. A slight precipitate may be present and can be dissolved by gently vortexing. This will not interfere with antibody performance.

    Specificity / Sensitivity

    Annexin A2 (D11G2) Rabbit mAb (BSA and Azide Free) recognizes endogenous levels of total annexin A2 protein. This antibody is not known or predicted to cross-react with other annexin family members.


    Species Reactivity:

    Human, Mouse, Rat, Monkey, Bovine, Pig


    The antigen sequence used to produce this antibody shares 100% sequence homology with the species listed here, but reactivity has not been tested or confirmed to work by CST. Use of this product with these species is not covered under our Product Performance Guarantee.

    Species predicted to react based on 100% sequence homology:

    Dog, Horse

    Source / Purification

    Monoclonal antibody is produced by immunizing animals with a synthetic peptide corresponding to residues surrounding Phe307 of human annexin A2 protein.

    Background

    Annexin A2 (ANXA2), also known as lipocortin II or calpactin-1 heavy chain, is a 36 kDa member of the annexin superfamily that binds phospholipids and other proteins in a calcium-dependent manner via annexin repeats (1). Annexin A2 contains four such repeats through which it mediates protein-protein and protein-lipid interactions (1-4). It forms a constitutive heterotetramer with S100A10, acting as a bridge between the actin cytoskeleton, plasma membrane, and endocytotic vesicle machinery (5-7). Originally identified as a protein inhibitor of phospholipase A2, annexin A2 has subsequently been shown to interact with an array of protein and non-protein partners, including F-actin, spectrin, SNARE complexes, RNA, and virus particles (4,6,8,9). Annexin A2 has also been shown to have receptor-like activity and is detected on the surface of macrophages and vascular endothelial cells where it mediates macrophage activation and Factor Xa signaling, respectively (10-13). Upregulation of annexin A2 at the cell surface is thought to be modulated by phosphorylation at Tyr23 by Src (14-18). Interestingly, phosphorylation at Tyr23 has recently been shown to be required for cell surface expression of annexin A2 where it mediates motility, invasiveness, and overall metastatic potential of certain pancreatic cancer cells (19,20). Annexin A2 has also been shown to be heavily phosphorylated on serine residues in response to PKC activation via a pleiotropic mechanism (21-23). For a complete list of curated phosphorylation sites on annexin A2, please see PhosphoSitePlus® at www.phosphosite.org.

    1. Barton, G.J. et al. (1991) Eur J Biochem 198, 749-60.
    2. Gerke, V. and Weber, K. (1985) EMBO J 4, 2917-20.
    3. Glenney, J.R. and Tack, B.F. (1985) Proc Natl Acad Sci USA 82, 7884-8.
    4. Gerke, V. and Weber, K. (1984) EMBO J 3, 227-33.
    5. Illien, F. et al. (2010) Biochim Biophys Acta 1798, 1790-6.
    6. Umbrecht-Jenck, E. et al. (2010) Traffic 11, 958-71.
    7. Jung, M.J. et al. (2010) Exp Cell Res 316, 1234-40.
    8. Filipenko, N.R. et al. (2004) J Biol Chem 279, 8723-31.
    9. Wright, J.F. et al. (1994) Biochem Biophys Res Commun 198, 983-9.
    10. Bhattacharjee, G. et al. (2008) Circ Res 102, 457-64.
    11. Pizzo, S.V. (2008) Circ Res 102, 389-91.
    12. Swisher, J.F. et al. (2007) J Leukoc Biol 82, 1174-84.
    13. Deora, A.B. et al. (2004) J Biol Chem 279, 43411-8.
    14. Huang, K.S. et al. (1986) Cell 46, 191-9.
    15. Erikson, E. et al. (1984) Mol Cell Biol 4, 77-85.
    16. Glenney, J.R. (1985) FEBS Lett 192, 79-82.
    17. Morel, E. and Gruenberg, J. (2009) J Biol Chem 284, 1604-11.
    18. de Graauw, M. et al. (2008) Mol Cell Biol 28, 1029-40.
    19. Nedjadi, T. et al. (2009) Br J Cancer 101, 1145-54.
    20. Zheng, L. et al. (2011) PLoS One 6, e19390.
    21. Gould, K.L. et al. (1986) Mol Cell Biol 6, 2738-44.
    22. Luo, W. et al. (2008) Mol Carcinog 47, 934-46.
    23. He, K.L. et al. (2011) J Biol Chem 286, 15428-39.

    Database Links

    UniProt ID: P07355


    Entrez-Gene Id: 302


    Limited Uses

    Except as otherwise expressly agreed in a writing signed by a legally authorized representative of CST, the following terms apply to Products provided by CST, its affiliates or its distributors. Any Customer's terms and conditions that are in addition to, or different from, those contained herein, unless separately accepted in writing by a legally authorized representative of CST, are rejected and are of no force or effect.

    Products are labeled with For Research Use Only or a similar labeling statement and have not been approved, cleared, or licensed by the FDA or other regulatory foreign or domestic entity, for any purpose. Customer shall not use any Product for any diagnostic or therapeutic purpose, or otherwise in any manner that conflicts with its labeling statement. Products sold or licensed by CST are provided for Customer as the end-user and solely for research and development uses. Any use of Product for diagnostic, prophylactic or therapeutic purposes, or any purchase of Product for resale (alone or as a component) or other commercial purpose, requires a separate license from CST. Customer shall (a) not sell, license, loan, donate or otherwise transfer or make available any Product to any third party, whether alone or in combination with other materials, or use the Products to manufacture any commercial products, (b) not copy, modify, reverse engineer, decompile, disassemble or otherwise attempt to discover the underlying structure or technology of the Products, or use the Products for the purpose of developing any products or services that would compete with CST products or services, (c) not alter or remove from the Products any trademarks, trade names, logos, patent or copyright notices or markings, (d) use the Products solely in accordance with CST Product Terms of Sale and any applicable documentation, and (e) comply with any license, terms of service or similar agreement with respect to any third party products or services used by Customer in connection with the Products.

    For Research Use Only. Not For Use In Diagnostic Procedures.
    Cell Signaling Technology is a trademark of Cell Signaling Technology, Inc.
    The Annexin V-FITC conjugate is a product manufactured for Cell Signaling Technology, Inc. by TAU Technologies BV.
    All other trademarks are the property of their respective owners. Visit our Trademark Information page.